Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 4
2015 6
2016 3
2018 3
2019 1
2020 9
2021 4
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity.
Migliavaca CB, Stein C, Colpani V, Barker TH, Ziegelmann PK, Munn Z, Falavigna M; Prevalence Estimates Reviews-Systematic Review Methodology Group (PERSyst). Migliavaca CB, et al. Among authors: colpani v. Res Synth Methods. 2022 May;13(3):363-367. doi: 10.1002/jrsm.1547. Epub 2022 Feb 23. Res Synth Methods. 2022. PMID: 35088937
Long-term Effect of Lifestyle Interventions on the Cardiovascular and All-Cause Mortality of Subjects With Prediabetes and Type 2 Diabetes: A Systematic Review and Meta-analysis.
Zucatti KP, Teixeira PP, Wayerbacher LF, Piccoli GF, Correia PE, Fonseca NKO, Moresco KS, Guerra BA, Maduré MG, Farenzena LP, Frankenberg AD, Brietzke E, Halpern B, Franco O, Colpani V, Gerchman F. Zucatti KP, et al. Among authors: colpani v. Diabetes Care. 2022 Nov 1;45(11):2787-2795. doi: 10.2337/dc22-0642. Diabetes Care. 2022. PMID: 36318674 Free article. Review.
Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials.
Spiazzi BF, Naibo RA, Wayerbacher LF, Piccoli GF, Farenzena LP, Londero TM, da Natividade GR, Zoldan M, Degobi NAH, Niches M, Lopes G, Boyko EJ, Utzschneider KM, Colpani V, Gerchman F. Spiazzi BF, et al. Among authors: colpani v. Diabetes Res Clin Pract. 2023 Apr;198:110621. doi: 10.1016/j.diabres.2023.110621. Epub 2023 Mar 13. Diabetes Res Clin Pract. 2023. PMID: 36921905
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysis.
Mesquita LA, Spiazzi BF, Piccoli GF, Nogara DA, da Natividade GR, Garbin HI, Wayerbacher LF, Wiercinski VM, Baggio VA, Zingano CP, Schwartsmann G, Lopes G, Petrie JR, Colpani V, Gerchman F. Mesquita LA, et al. Among authors: colpani v. Diabetes Obes Metab. 2024 May;26(5):1929-1940. doi: 10.1111/dom.15509. Epub 2024 Feb 23. Diabetes Obes Metab. 2024. PMID: 38389430
43 results